Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab

Tsuru T 1 , Terao K , Murakami M , Matsutani T , Suzaki M , Amamoto T Show all authors , Nakashima H , Akiyama A , Nishimoto N

Affiliations 

  • 1 Medical Co. LTA PS clinic , Fukuoka , Japan
Mod Rheumatol, 2014 May;24(3):511-6.
PMID: 24252023 DOI: 10.3109/14397595.2013.843743

Abstract

To evaluate humoral immune response to influenza vaccine and polysaccharide pneumococcal vaccine in patients with rheumatoid arthritis (RA) or Castleman's disease (CD) during tocilizumab therapy.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications